Emma is currently Chief Commercial Officer (CCO) at INOVIQ Ltd (ASX: IIQ), commercialising next generation diagnostics and therapeutics for cancer.
She has worked in leadership positions in large multinationals, Illumina Inc (NASDAQ: ILMN) and CSL Limited (ASX: CSL), as well as small biotech, both ASX-listed and private. Her experience spans business development, corporate strategy, commercial development and R&D program management.
Emma has significant voluntary board and committee experience, including as Non-Executive Director at Startup Shakeup Ltd, member of the AusBiotech Victorian Committee, Life Sciences Member and Advisor at SBE Australia, and Guest of the Chair at MTPConnect (board observer role).
She trained initially as a molecular biologist and gained her PhD in Medicine from the University of Melbourne, followed by postdoctoral studies at Monash University. Emma holds an MBA from RMIT University, and is a graduate of the Australian Institute of Company Directors and the Wade Institute’s Venture Capital Catalyst.
